All Entities (500)
Every published entity page, grouped by category.
Anatomy (1)
Biological Process (23)
- (chemo)radiotherapy
- Angiogenesis
- Anti-inflammatory cytokines
- Apoptosis
- Autophagy
- Blood–brain barrier
- Cancer immunotherapy
- Cellular senescence
- Cuproptosis
- Depressive symptoms
- DNA methylation
- Ferroptosis
- Human gut flora
- Inflammation
- Insulin resistance
- Lipid metabolism
- Neuroinflammation
- Oxidative stress
- Photochemotherapy
- Proinflammatory cytokine
- Pyroptosis
- Senescence
- Tumor microenvironment
Cellular Component (14)
Chemical (51)
- Aminolevulinic acid
- Apigenin
- Berberine
- Bisphenol A
- Calcium
- Camptothecin
- Cannabidiol
- Chitosan
- Copper
- Copper(2+)
- Curcumin
- Cyclosporine
- Cysteine
- DL-homocysteine
- Dopamine
- Epigallocatechin gallate
- Gallic acid
- Glucose
- Glutathione
- Hesperidin
- Hyaluronic acid
- Hydrogen peroxide
- Hydrogen sulfide
- Indocyanine green
- Irinotecan
- Kaempferol
- L-arginine
- L-glutamine
- Lipid
- Luteolin
- Messenger RNA
- Nitric Oxide
- Oxygen
- Paracetamol
- Pectin
- Phenylalanine
- Polyethylene glycol
- Polysaccharide
- Prostaglandin E2
- Quercetin
- Reactive oxygen species
- Resveratrol
- Rosmarinic acid
- Selenium
- Selenium nanoparticles
- Silver
- Small interfering RNA
- Ubidecarenone
- Uric acid
- Zinc
- Zinc oxide nanoparticles
Clinical Metric (15)
Disease (37)
- Acute kidney injury
- Alzheimer's disease
- Anxiety
- Breast cancer
- Cancer
- Cardiovascular disease
- Cognitive decline
- Colorectal cancer
- COVID-19
- Depression
- Diabetes
- Diabetic retinopathy
- Fibrosis
- Gestational diabetes
- Glioblastoma
- Glioma
- Heart failure
- Hepatitis B
- Hepatocellular carcinoma
- Hypertension
- Ischemic stroke
- Lung cancer
- Metabolic dysfunction associated steatohepatitis
- Metabolic dysfunction–associated steatotic liver disease
- Mild cognitive impairment
- Non-small cell lung cancer
- Obesity
- Osteoporosis
- Parkinson's disease
- Respiratory syncytial virus
- Sarcopenia
- Stomach cancer
- Stroke
- Triple-negative breast cancer
- Type 2 diabetes
- Type-1 diabetes
- Ulcerative colitis
Gene (27)
- BECN1
- BRAF
- BRAF V600E
- BRCA1
- BRCA2 DNA repair associated
- Cystic fibrosis transmembrane conductance regulator
- DNA
- EGFR
- ESR1
- GSK3B
- Heme oxygenase 1
- HER2 exon 20 insertion
- Interleukin 10
- Iron
- Jun proto-oncogene, AP-1 transcription factor subunit
- KRAS
- KRAS G12C
- MIR21
- Myc
- NAMPT
- NRAS
- PIK3CA
- Platelet-derived growth factor receptor alpha
- TGFB1
- TP53
- Triggering receptor expressed on myeloid cells 2
- Vascular endothelial growth factor
Organism (12)
Other (4)
Pathway (17)
- AMPK/mTOR
- CD44/JAK2/STAT3 signaling pathway
- cGAS-STING pathway
- cGAS-STING/NF-κB signaling pathway
- E2F2/PI3K/AKT signaling pathway
- JAK2/STAT3 signaling pathway
- MAPK signaling pathway
- Mitochondrial respiratory chain complex I
- NF-κB
- Nrf-2-SLC7A11-GSH pathway
- PD-1/PD-L1
- PI3K/Akt signaling pathway
- PI3K/AKT/mTOR pathway
- SIRT1/HIF-1α pathway
- SIRT6/NRF2/GPX4 signaling pathway
- Transforming growth factor-β (TGF-β) pathway
- Wnt/β-catenin pathway
Protein (142)
- Acetylcholinesterase (AChE)
- Acid α-glucosidase (AAG)
- Acyl-CoA synthetase long-chain family member 4 (ACSL4)
- Adiponectin (APN)
- Alpha-fetoprotein (AFP)
- AMP-activated protein kinase alpha 1 (AMPKα1)
- AMP-activated protein kinases
- Amylase
- Amylase alpha 1C (AMY1C)
- Amyloid beta (Aβ)
- Anaplastic Lymphoma Kinase (ALK)
- Androgen receptor (AR)
- Angiotensin-converting enzyme 2 (ACE2)
- Aurora kinase A (AURKA)
- B cell maturation antigen (BCMA)
- B7 homolog 3 (B7-H3)
- BCL2 apoptosis regulator
- BCL2 Associated X, Apoptosis Regulator (BAX)
- Beta-catenin
- Beta-secretase 1 (BACE1)
- Brain-derived neurotrophic factor (BDNF)
- Bromodomain-containing protein 4 (BRD4)
- Bruton tyrosine kinase (BTK)
- Butyrylcholinesterase (BCHE)
- C-C motif chemokine ligand 2
- C-reactive protein (CRP)
- C-X-C motif chemokine ligand 8 (CXCL8)
- C-X-C motif chemokine receptor 4
- Calcitonin gene-related peptide (CGRP)
- Carbonic anhydrase (CA)
- Carbonic anhydrase IX (CA IX)
- Carcinoembryonic antigen (CEA)
- Cardiac troponin I (TNNI3)
- Caspase-1 (CASP1)
- Caspase-3 (CASP3)
- Catalase (CAT)
- Cathepsin B (CTSB)
- CD274 molecule
- CD3+
- CD44
- Cereblon (CRBN)
- Chimeric antigen receptor
- Cluster of Differentiation 19 (CD19)
- Cluster of Differentiation 28 (CD28)
- Cluster of Differentiation 47 (CD47)
- Coagulation factor II (F2)
- Collagen
- Cyclin-dependent kinase 1 (CDK1)
- Cyclin-dependent kinase 2 (CDK2)
- Cyclooxygenase 2 (COX-2)
- Cytochrome P450 3A4 (CYP3A4)
- Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)
- Dipeptidyl peptidase 4 (DPP-4)
- DNA topoisomerase I
- DNMT1
- Fibroblast Activation Protein alpha (FAP)
- Fms-like tyrosine kinase 3 (FLT3)
- Focal adhesion kinase (FAK)
- Forkhead box O3 (FOXO3)
- Galectin-3 (LGALS3)
- Gasdermin D (GSDMD)
- Gasdermin E (GSDME)
- Glial fibrillary acidic protein
- Glucagon-like peptide-1 (GLP-1)
- Glucagon-like peptide-1 receptor (GLP-1R)
- Glucose oxidase (GOD)
- Glucose-6-phosphate dehydrogenase
- Glucose-dependent insulinotropic polypeptide (GIP)
- Glucosidase
- Glutamate carboxypeptidase II (GCPII)
- Glutathione Peroxidase 4 (GPX4)
- Glypican-3 (GPC3)
- Heat shock protein 90-alpha (Hsp90α)
- Hemagglutinin
- Hepatocyte Nuclear Factor 1 Alpha (HNF1A)
- High mobility group box 1 (HMGB1)
- Histone deacetylase 6 (HDAC6)
- Human epidermal growth factor receptor 2 (HER2)
- Human serum albumin
- Hypoxia inducible factor 1 subunit alpha
- Indoleamine 2,3-dioxygenase 1 (IDO1)
- Insulin
- Insulin-like growth factor 1 (IGF-1)
- Interferon
- Interferon gamma (IFNG)
- Interferon regulatory factor 1 (IRF1)
- Interleukin 17A (IL-17A)
- Interleukin-17 family
- Interleukin-1β (IL-1β)
- Interleukin-2 (IL-2)
- Interleukin-6 (IL-6)
- JAK2
- Kelch-like ECH-associated protein 1 (KEAP1)
- KLF4
- Leptin (LEP)
- Matrix Metalloproteinase-9 (MMP-9)
- Mechanistic target of rapamycin (mTOR)
- Met
- Microtubule-associated protein tau (MAPT)
- Mitogen-Activated Protein Kinase 1 (MAPK1)
- Mitogen-activated protein kinase 8 (MAPK8)
- MKI67
- MYC proto-oncogene (MYC)
- Myeloperoxidase
- Neurofilament Light Chain (NF-L)
- NLRP3
- NLRP3 inflammasome
- Nuclear factor erythroid 2-related factor 2 (NRF2)
- Nuclear receptor subfamily 1 group H member 4 (NR1H4)
- p-Tau217
- Peptides
- Peroxisome proliferator-activated receptor alpha (PPARα)
- Phosphatase and Tensin Homolog (PTEN)
- Phosphatidylinositol 3-kinase (PI3K)
- Poly(ADP-ribose) polymerase 1 (PARP1)
- Programmed cell death 1 (PD-1)
- Proprotein convertase subtilisin/kexin type 9 (PCSK9)
- Prostate specific membrane antigen
- Protein kinase B (PKB)
- Protein tyrosine phosphatase non-receptor type 1 (PTPN1)
- Secreted phosphoprotein 1 (SPP1)
- Signal Transducer and Activator of Transcription 3 (STAT3)
- Sodium-glucose cotransporter 2 (SGLT2)
- Spleen tyrosine kinase (SYK)
- Stimulator of Interferon Genes (STING)
- Superoxide Dismutase (SOD)
- T cell immunoreceptor with Ig and ITIM domains (TIGIT)
- T-cell receptor (TCR)
- TNF receptor superfamily member 5 (TNFRSF5)
- Toll like receptor 2
- Toll-like receptor 4 (TLR4)
- Toll-like receptor 7/8
- Transforming growth factor beta (TGF-β)
- Transforming growth factor, beta 1
- Tumor necrosis factor-α (TNF-α)
- Tumor-associated calcium signal transducer 2 (TACSTD2)
- Tyrosinase (TYR)
- Ubiquitin specific peptidase 7
- Vascular Endothelial Growth Factor A (VEGFA)
- Vascular endothelial growth factor receptor 2 (VEGFR2)
- Yes-associated protein 1 (YAP1)
- α-synuclein (SNCA)
Technology (10)
Therapy (147) cluster tree →
- (S)-(−)-colchicine
- [177Lu]Lu-PSMA-617
- Abemaciclib
- Adalimumab
- Aflibercept
- Alectinib
- Amphotericin B
- Anti-PD-1 therapy
- Anti-PD-L1
- Antibody-drug conjugate
- Antimicrobial
- Antiseizure Medication
- Artemisinin
- Aspirin
- Atezolizumab
- Atorvastatin
- Azithromycin
- Bacillus Calmette-Guérin
- Belimumab
- Bevacizumab
- Bispecific antibodies
- Bortezomib
- Bupivacaine
- Cabozantinib
- Caelyx
- Calcineurin inhibitor
- Capecitabine
- CAR-T cells
- Carbamazepine
- Carboplatin
- Ceftazidime-avibactam
- Celecoxib
- Cetuximab
- Checkpoint inhibitor
- Chemoimmunotherapy
- Chemoradiotherapy
- Ciprofloxacin
- Cisplatin
- Cisplatin/fluorouracil
- Cognitive behavioral therapy
- Combination therapy
- Continuous positive airway pressure
- COVID-19 vaccine
- Cyclin-dependent kinase 4/6 inhibitors
- Cyclophosphamide
- Dapagliflozin
- Daratumumab
- Dasatinib
- Dexamethasone
- Dexmedetomidine
- Direct oral anticoagulants
- Docetaxel
- Dolutegravir
- Donepezil
- Doxorubicin
- Doxycycline
- Dupilumab
- Durvalumab
- Electroacupuncture
- Empagliflozin
- Enfortumab vedotin
- Everolimus
- Faricimab
- Fenofibrate
- Finerenone
- Fluorouracil
- Gefitinib
- Gemcitabine
- Gene therapy
- Glucagon-like peptide-1 agonist
- Glucocorticoid
- Histone deacetylase inhibitors
- HPV vaccination
- HPV vaccine
- Ibrutinib
- Ibuprofen
- Imatinib
- Immunization
- Immunotherapy
- Infliximab
- Influenza vaccination
- Influenza vaccine
- Insulin Therapy
- Intravitreal rituximab
- Ipilimumab
- Janus kinase inhibitors
- Lenalidomide
- Lenvatinib
- Levodopa
- Lidocaine
- Liraglutide
- Melatonin
- Meropenem
- Mesalazine
- Metformin
- Methotrexate
- Monoclonal antibody
- Niraparib
- Nirsevimab
- Nivolumab
- Ocrelizumab
- Olaparib
- Osimertinib
- Oxaliplatin
- Paclitaxel
- Palbociclib
- PARP inhibitor
- PD-1/PD-L1 blockade
- Pembrolizumab
- Photobiomodulation
- Photothermal therapy
- Pioglitazone
- Platelet-rich plasma
- Platinum
- Proteolysis-targeting chimeras
- Proton therapy
- Quercetin hydrogel
- Radiation therapy
- Ranibizumab
- Repetitive transcranial magnetic stimulation
- Rituximab
- Rivaroxaban
- RNA vaccine
- Robot-assisted radical prostatectomy
- Romosozumab
- Rutin
- Ruxolitinib
- Semaglutide
- Simvastatin
- Sirolimus
- Sodium glucose cotransporter-2 (SGLT2) inhibitors
- Sorafenib
- Statin
- Sunitinib
- Taxane
- Temozolomide
- Tirzepatide
- Tislelizumab
- Tofacitinib
- Trametinib
- Trastuzumab
- Tyrosine-kinase inhibitor
- Upadacitinib
- Vancomycin
- Venetoclax
- Vitamin D
- Vorinostat